Friday, shares of Novo Nordisk A/S (NVO) are sliding following the announcement of safety results of phase 2a clinical trial of ...
Cash position of €10.3 million as of June 30, 2024 Net loss of €8.9 million as of June 30, 2024, comparable to the same period in 2023 Debt limited to a state-guaranteed loan amounting ...
Latin America Insulin Market was valued at US$ 2,855.1 million in 2022 and is projected to attain a valuation of US$ 3,857.50 million by 2031 at a CAGR of 3.4% During the Forecast Period 2023–2031.